You can also report side effects directly to Therapeutic Goods Administration (TGA) in accordance with their requirements.
If you experience any side effects when taking Remsima® or any other medicine, talk to your doctor, pharmacist or nurse.
This includes possible side effects not listed in the packaging leaflet.
You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine.
1. Jin, Jing-Fen et al. “The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.” Patient preference and adherence vol. 9 923-42. 2 Jul. 2015, doi:10.2147/PPA.S87271
SC, subcutaneous; FAQ, frequently asked questions
The link you have selected will take you to a third-party website. It is not under the review or control of Celltrion Healthcare and the company does not review or control the contents. The company does not endorse the content, its accuracy or any practices and standards contained in the website.
Please confirm if you wish to follow the link.